The COSTA II trial is a randomized.

The COSTA II trial is a randomized, single-blind, non-inferiority study comparing Conor Medsystems ‘ Costa cobalt chromium paclitaxel – eluting stent with Boston Scientific Taxu Express2 drug – eluting stents in the treatment of de novo lesions in patients with single or multi-vessel coronary artery disease. It includes 1,700 patients from more than 70 clinical centers.

Johnson & Johnson acquired Conor Medsystems, in February this year.About Conor MedsystemsConor Medsystems develops innovative controlled vascular drug delivery technologies and has primarily primarily on the development of drug-eluting stent treatment of coronary heart diseases. For more information about Conor Medsystems and controlled vascular delivery.Information on all the deliveries and neonatal deaths in Quang Ninh province in northern Vietnam 2005 was collected through questionnaires and group interviews by care personnel on 187 community health Center and 18 hospitals, as well with 1372 town health personnel. Infos was health center health facility records. The team then compared that results to official statistics of Provincial Health office.

Other entries from category "immunology":

Random entries